<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">35492620</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>03</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Print">1664-042X</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>13</Volume>
            <PubDate>
              <Year>2022</Year>
            </PubDate>
          </JournalIssue>
          <Title>Frontiers in physiology</Title>
          <ISOAbbreviation>Front Physiol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Editorial: Mechanisms of Inflammation and Fibrosis Interplays in the Digestive Diseases.</ArticleTitle>
        <Pagination>
          <StartPage>906742</StartPage>
          <MedlinePgn>906742</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">906742</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.3389/fphys.2022.906742</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Masamune</LastName>
            <ForeName>Atsushi</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hamada</LastName>
            <ForeName>Shin</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016421">Editorial</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>04</Month>
          <Day>14</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Front Physiol</MedlineTA>
        <NlmUniqueID>101549006</NlmUniqueID>
        <ISSNLinking>1664-042X</ISSNLinking>
      </MedlineJournalInfo>
      <CommentsCorrectionsList>
        <CommentsCorrections RefType="CommentOn">
          <RefSource>Editorial on the Research Topic Mechanisms of Inflammation and Fibrosis Interplays in the Digestive Diseases</RefSource>
        </CommentsCorrections>
      </CommentsCorrectionsList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">all-trans retinoic acid</Keyword>
        <Keyword MajorTopicYN="N">anti-stromal therapy</Keyword>
        <Keyword MajorTopicYN="N">meflin</Keyword>
        <Keyword MajorTopicYN="N">pancreatic cancer</Keyword>
        <Keyword MajorTopicYN="N">pancreatic fibrosis</Keyword>
        <Keyword MajorTopicYN="N">pancreatic stellate cells</Keyword>
        <Keyword MajorTopicYN="N">vitamin D</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>30</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>2</Day>
          <Hour>6</Hour>
          <Minute>12</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>3</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>3</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35492620</ArticleId>
        <ArticleId IdType="pmc">PMC9048022</ArticleId>
        <ArticleId IdType="doi">10.3389/fphys.2022.906742</ArticleId>
        <ArticleId IdType="pii">906742</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>
Apte M. V., Haber P. S., Applegate T. L., Norton I. D., McCaughan G. W., Korsten M. A., et al.  (1998). Periacinar Stellate Shaped Cells in Rat Pancreas: Identification, Isolation, and Culture. Gut
43, 128–133. 10.1136/gut.43.1.128
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/gut.43.1.128</ArticleId>
            <ArticleId IdType="pmc">PMC1727174</ArticleId>
            <ArticleId IdType="pubmed">9771417</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Bachem M. G., Schneider E., Gross H., Weidenbach H., Schmid R. M., Menke A., et al.  (1998). Identification, Culture, and Characterization of Pancreatic Stellate Cells in Rats and Humans. Gastroenterology
115, 421–432. 10.1016/s0016-5085(98)70209-4
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s0016-5085(98)70209-4</ArticleId>
            <ArticleId IdType="pubmed">9679048</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Carapuça E. F., Gemenetzidis E., Feig C., Bapiro T. E., Williams M. D., Wilson A. S., et al.  (2016). Anti-stromal Treatment Together with Chemotherapy Targets Multiple Signalling Pathways in Pancreatic Adenocarcinoma. J. Pathol.
239, 286–296. 10.1002/path.4727
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/path.4727</ArticleId>
            <ArticleId IdType="pmc">PMC5025731</ArticleId>
            <ArticleId IdType="pubmed">27061193</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Erkan M., Adler G., Apte M. V., Bachem M. G., Buchholz M., Detlefsen S., et al.  (2012). StellaTUM: Current Consensus and Discussion on Pancreatic Stellate Cell Research. Gut
61, 172–178. 10.1136/gutjnl-2011-301220
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/gutjnl-2011-301220</ArticleId>
            <ArticleId IdType="pmc">PMC3245897</ArticleId>
            <ArticleId IdType="pubmed">22115911</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Erkan M. (2013). The Role of Pancreatic Stellate Cells in Pancreatic Cancer. Pancreatology
13, 106–109. 10.1016/j.pan.2013.01.008
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.pan.2013.01.008</ArticleId>
            <ArticleId IdType="pubmed">23561966</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Hamada S., Matsumoto R., Masamune A. (2022). HIF-1 and NRF2; Key Molecules for Malignant Phenotypes of Pancreatic Cancer. Cancers (Basel)
14, 411. 10.3390/cancers14020411
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/cancers14020411</ArticleId>
            <ArticleId IdType="pmc">PMC8773475</ArticleId>
            <ArticleId IdType="pubmed">35053572</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Helms E. J., Berry M. W., Chaw R. C., Dufort C. C., Sun D., Onate M. K., et al.  (2022). Mesenchymal Lineage Heterogeneity Underlies Nonredundant Functions of Pancreatic Cancer-Associated Fibroblasts. Cancer Discov.
12, 484–501. 10.1158/2159-8290.cd-21-0601
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/2159-8290.cd-21-0601</ArticleId>
            <ArticleId IdType="pmc">PMC8831457</ArticleId>
            <ArticleId IdType="pubmed">34548310</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Hosein A. N., Brekken R. A., Maitra A. (2020). Pancreatic Cancer Stroma: an Update on Therapeutic Targeting Strategies. Nat. Rev. Gastroenterol. Hepatol.
17, 487–505. 10.1038/s41575-020-0300-1
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41575-020-0300-1</ArticleId>
            <ArticleId IdType="pmc">PMC8284850</ArticleId>
            <ArticleId IdType="pubmed">32393771</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Iwata K., Mikami Y., Kato M., Yahagi N., Kanai T. (2021). Pathogenesis and Management of Gastrointestinal Inflammation and Fibrosis: from Inflammatory Bowel Diseases to Endoscopic Surgery. Inflamm. Regener
41, 21. 10.1186/s41232-021-00174-7
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s41232-021-00174-7</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Kocher H. M., Basu B., Froeling F. E. M., Sarker D., Slater S., Carlin D., et al.  (2020). Phase I Clinical Trial Repurposing All-Trans Retinoic Acid as a Stromal Targeting Agent for Pancreatic Cancer. Nat. Commun.
11, 4841. 10.1038/s41467-020-18636-w
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41467-020-18636-w</ArticleId>
            <ArticleId IdType="pmc">PMC7518421</ArticleId>
            <ArticleId IdType="pubmed">32973176</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Manoukian P., Bijlsma M., Van Laarhoven H. (2021). The Cellular Origins of Cancer-Associated Fibroblasts and Their Opposing Contributions to Pancreatic Cancer Growth. Front. Cel Dev. Biol.
9, 743907. 10.3389/fcell.2021.743907
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fcell.2021.743907</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Masamune A., Shimosegawa T. (2013). Pancreatic Stellate Cells - Multi-Functional Cells in the Pancreas. Pancreatology
13, 102–105. 10.1016/j.pan.2012.12.058
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.pan.2012.12.058</ArticleId>
            <ArticleId IdType="pubmed">23561965</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Mizutani Y., Kobayashi H., Iida T., Asai N., Masamune A., Hara A., et al.  (2019). Meflin-positive Cancer-Associated Fibroblasts Inhibit Pancreatic Carcinogenesis. Cancer Res.
79, 5367–5381. 10.1158/0008-5472.can-19-0454
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/0008-5472.can-19-0454</ArticleId>
            <ArticleId IdType="pubmed">31439548</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Mukai Y., Yamada D., Eguchi H., Iwagami Y., Asaoka T., Noda T., et al.  (2018). Vitamin D Supplementation Is a Promising Therapy for Pancreatic Ductal Adenocarcinoma in Conjunction with Current Chemoradiation Therapy. Ann. Surg. Oncol.
25, 1868–1879. 10.1245/s10434-018-6431-8
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1245/s10434-018-6431-8</ArticleId>
            <ArticleId IdType="pubmed">29675761</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Murray E. R., Menezes S., Henry J. C., Williams J. L., Alba-Castellón L., Baskaran P., et al.  (2022). Disruption of Pancreatic Stellate Cell Myofibroblast Phenotype Promotes Pancreatic Tumor Invasion. Cel Rep.
38, 110227. 10.1016/j.celrep.2021.110227
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.celrep.2021.110227</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Nakai Y., Isayama H., Ijichi H., Sasaki T., Takahara N., Ito Y., et al.  (2013). A Multicenter Phase II Trial of Gemcitabine and Candesartan Combination Therapy in Patients with Advanced Pancreatic Cancer: GECA2. Invest. New Drugs
31, 1294–1299. 10.1007/s10637-013-9972-5
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10637-013-9972-5</ArticleId>
            <ArticleId IdType="pubmed">23690239</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Rhim A. D., Oberstein P. E., Thomas D. H., Mirek E. T., Palermo C. F., Sastra S. A., et al.  (2014). Stromal Elements Act to Restrain, rather Than Support, Pancreatic Ductal Adenocarcinoma. Cancer Cell
25, 735–747. 10.1016/j.ccr.2014.04.021
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ccr.2014.04.021</ArticleId>
            <ArticleId IdType="pmc">PMC4096698</ArticleId>
            <ArticleId IdType="pubmed">24856585</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Sherman M. H., Yu R. T., Engle D. D., Ding N., Atkins A. R., Tiriac H., et al.  (2014). Vitamin D Receptor-Mediated Stromal Reprogramming Suppresses Pancreatitis and Enhances Pancreatic Cancer Therapy. Cell
159, 80–93. 10.1016/j.cell.2014.08.007
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2014.08.007</ArticleId>
            <ArticleId IdType="pmc">PMC4177038</ArticleId>
            <ArticleId IdType="pubmed">25259922</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Sunami Y., Häußler J., Kleeff J. (2020). Cellular Heterogeneity of Pancreatic Stellate Cells, Mesenchymal Stem Cells, and Cancer-Associated Fibroblasts in Pancreatic Cancer. Cancers (Basel)
12, 3770. 10.3390/cancers12123770
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/cancers12123770</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Vaish U., Jain T., Are A. C., Dudeja V. (2021). Cancer-associated Fibroblasts in Pancreatic Ductal Adenocarcinoma: An Update on Heterogeneity and Therapeutic Targeting. Ijms
22, 13408. 10.3390/ijms222413408
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms222413408</ArticleId>
            <ArticleId IdType="pmc">PMC8706283</ArticleId>
            <ArticleId IdType="pubmed">34948209</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Wang F.-D., Zhou J., Chen E.-Q. (2022). Molecular Mechanisms and Potential New Therapeutic Drugs for Liver Fibrosis. Front. Pharmacol.
13, 787748. 10.3389/fphar.2022.787748
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fphar.2022.787748</ArticleId>
            <ArticleId IdType="pmc">PMC8874120</ArticleId>
            <ArticleId IdType="pubmed">35222022</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Zhang Z., Zhang H., Liu T., Chen T., Wang D., Tang D. (2021). Heterogeneous Pancreatic Stellate Cells Are Powerful Contributors to the Malignant Progression of Pancreatic Cancer. Front. Cel Dev. Biol.
9, 783617. 10.3389/fcell.2021.783617
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fcell.2021.783617</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
